Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control

医学 沙库比林、缬沙坦 血糖性 缬沙坦 沙库比林 重症监护医学 内科学 心脏病学 胰岛素 血压
作者
Jelena Seferović,Scott D. Solomon,Ellen W. Seely
出处
期刊:Therapeutic Advances in Endocrinology and Metabolism [SAGE]
卷期号:11: 204201882097044-204201882097044 被引量:27
标识
DOI:10.1177/2042018820970444
摘要

Heart failure (HF) and diabetes mellitus (DM) frequently coexist, with a prevalence of DM of 35-40% in patients with HF, independent of the level of impairment of the ejection fraction (EF). Furthermore, DM is considered a strong independent risk factor for the progression of HF with either preserved or reduced EF and is associated with poor prognosis. The ability of neprilysin inhibitors to elevate levels of biologically active natriuretic peptides has made them a potential therapeutic approach in HF. In the Prospective comparison of ARNi with ACEi to Determine Impact on Global Mortality and morbidity in Heart Failure (PARADIGM-HF) trial, a dual-acting angiotensin-receptor-neprilysin inhibitor, sacubitril/valsartan was superior to enalapril in reducing the risks of death and HF hospitalization in patients with HF with reduced EF. In addition, in a post-hoc analysis of this trial, among patients with DM, treatment with sacubitril/valsartan resulted in improved glycemic control compared with enalapril. Also, there are additional studies suggesting beneficial metabolic effects of this class of drugs. In this review we discuss potential mechanisms of sacubitril/valsartan effect on glycemic control. Sacubitril/valsartan concomitantly blocks the renin-angiotensin system and inhibits neprilysin, a ubiquitous enzyme responsible for the breakdown of more than 50 vasoactive peptides, including the biologically active natriuretic peptides, bradykinin, angiotensin I and II, endothelin 1, glucagon, glucagon-like peptide-1, insulin-B chain, and others. There are a number of potential mechanisms by which inhibition of neprilysin may lead to improvement in glycemic control, with most evidence suggesting modulation of neprilysin circulating substrates. Although there is some evidence suggesting the improvement of glucose metabolism by renin-angiotensin system inhibition, this effect is most likely modest. As these mechanisms are not fully understood, detailed mechanistic studies, as well as large randomized clinical trials in patients with DM, are needed to further clarify beneficial metabolic properties of sacubitril/valsartan.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
丘比特应助aliuliu采纳,获得10
1秒前
顺利念双发布了新的文献求助10
2秒前
yue发布了新的文献求助30
2秒前
5秒前
猪猪侠关注了科研通微信公众号
6秒前
m13965062353完成签到,获得积分10
8秒前
彭于晏应助mmyhn采纳,获得10
8秒前
cy发布了新的文献求助10
8秒前
帅气的Q发布了新的文献求助10
11秒前
11秒前
12秒前
顺利念双完成签到,获得积分10
13秒前
橙子发布了新的文献求助30
14秒前
赵红晓完成签到,获得积分20
16秒前
月上卿云完成签到,获得积分10
19秒前
20秒前
21秒前
天天快乐应助科研通管家采纳,获得10
21秒前
JamesPei应助科研通管家采纳,获得10
21秒前
科研通AI2S应助科研通管家采纳,获得10
21秒前
李爱国应助科研通管家采纳,获得10
21秒前
桐桐应助ABS采纳,获得10
21秒前
英俊的铭应助科研通管家采纳,获得10
21秒前
HCLonely应助科研通管家采纳,获得10
21秒前
三新荞应助科研通管家采纳,获得10
21秒前
Xutz应助科研通管家采纳,获得10
21秒前
不配.应助科研通管家采纳,获得10
21秒前
22秒前
不配.应助科研通管家采纳,获得10
22秒前
25秒前
25秒前
迷路的沛蓝完成签到,获得积分10
27秒前
28秒前
敏感的豪英完成签到,获得积分10
29秒前
30秒前
Jasper应助可乐就是力量z采纳,获得10
31秒前
Veronica发布了新的文献求助10
31秒前
小鱼呆呆脑完成签到,获得积分10
31秒前
szong完成签到,获得积分10
32秒前
zhaozhao228发布了新的文献求助10
33秒前
高分求助中
歯科矯正学 第7版(或第5版) 1004
The late Devonian Standard Conodont Zonation 1000
Semiconductor Process Reliability in Practice 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 600
Zeitschrift für Orient-Archäologie 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3237590
求助须知:如何正确求助?哪些是违规求助? 2883189
关于积分的说明 8229210
捐赠科研通 2551399
什么是DOI,文献DOI怎么找? 1379680
科研通“疑难数据库(出版商)”最低求助积分说明 648839
邀请新用户注册赠送积分活动 624464